Where we are

We are dedicated to ensuring that as many people worldwide understand more about rare melanocortin-4 receptor (MC4R) pathway diseases. As such, we now have a presence in 19 countries and partnerships in one. Rhythm Pharmaceuticals International is headquartered in the Netherlands.